Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Advances in Therapy
|
June 19, 2017
When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development
Nektarios Oraiopoulos, William C N Dunlop
Advances in Therapy
|
September 7, 2015
The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European Countries
Ashok Jha, Alex Upton, William C N Dunlop, et al.
Health Policy (Amsterdam, Netherlands)
|
March 24, 2018
Innovative pharmaceutical pricing agreements in five European markets: A survey of stakeholder attitudes and experience
William C N Dunlop, Alexandra Staufer, Pierre Levy, et al.
Journal of Medical Economics
|
April 14, 2016
Examining the association between pain severity and quality-of-life, work-productivity loss, and healthcare resource use among European adults diagnosed with pain
Edward A Witt, James Kenworthy, Gina Isherwood, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 23, 2018
Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom
Sue Langham, Antony Wright, James Kenworthy, et al.
Cancer Management and Research
|
November 19, 2021
The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?
Michael Patrick Lux, Oriana Ciani, William C N Dunlop, et al.
Addiction Science & Clinical Practice
|
February 26, 2017
A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependence
Mersha Chetty, James J Kenworthy, Sue Langham, et al.
Journal of Medical Economics
|
June 9, 2018
Cost-effectiveness modeling for neuropathic pain treatments: investigating the relative importance of parameters using an open-source model
Matthew Hirst, Matthew W Bending, Gianluca Baio, et al.
Journal of Medical Economics
|
May 11, 2017
Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study
James Kenworthy, Yunni Yi, Antony Wright, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
May 14, 2018
Cost-utility analysis of an intervention designed to reduce the critical handling error of insufficient inspiratory effort
Rebecca Forster, Aran Ratcliffe, Megan Lewis, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Advances in Therapy
|
June 19, 2017
When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development
Nektarios Oraiopoulos, William C N Dunlop
Advances in Therapy
|
September 7, 2015
The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European Countries
Ashok Jha, Alex Upton, William C N Dunlop, et al.
Health Policy (Amsterdam, Netherlands)
|
March 24, 2018
Innovative pharmaceutical pricing agreements in five European markets: A survey of stakeholder attitudes and experience
William C N Dunlop, Alexandra Staufer, Pierre Levy, et al.
Journal of Medical Economics
|
April 14, 2016
Examining the association between pain severity and quality-of-life, work-productivity loss, and healthcare resource use among European adults diagnosed with pain
Edward A Witt, James Kenworthy, Gina Isherwood, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 23, 2018
Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom
Sue Langham, Antony Wright, James Kenworthy, et al.
Cancer Management and Research
|
November 19, 2021
The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?
Michael Patrick Lux, Oriana Ciani, William C N Dunlop, et al.
Addiction Science & Clinical Practice
|
February 26, 2017
A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependence
Mersha Chetty, James J Kenworthy, Sue Langham, et al.
Journal of Medical Economics
|
June 9, 2018
Cost-effectiveness modeling for neuropathic pain treatments: investigating the relative importance of parameters using an open-source model
Matthew Hirst, Matthew W Bending, Gianluca Baio, et al.
Journal of Medical Economics
|
May 11, 2017
Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study
James Kenworthy, Yunni Yi, Antony Wright, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
May 14, 2018
Cost-utility analysis of an intervention designed to reduce the critical handling error of insufficient inspiratory effort
Rebecca Forster, Aran Ratcliffe, Megan Lewis, et al.
Page
of 2